Celleron Therapeutics Ltd - Company Review
Celleron Therapeutics Ltd - Company ReviewSummary
Celleron Therapeutics Ltd (Celleron) is a healthcare solutions provider that offers cancer therapies. The company develops and markets cancer therapies and technologies that improve the performance of regular cancer treatments. Its products include CXD101, T-ARG-et and Bromo-FIX. Celleron’s CXD101 is novel HDACinhibitor with multiple positive differentiation properties from competing products for predictive biomarker. The company develops biomarkers using epigenetic techniques that match drugs to responsive disease. Its technologies are used to develop a new class of mechanism based cancer drugs to improve the success rates of treatment and reduce the side effects. The company provides cancer research, drug development and clinical practice services. Celleron is headquartered in Abingdon, the UK.
This comprehensive company report of Celleron Therapeutics Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.